26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

interleukin-13 (IL13) 410 interleukin-14 (IL14)<br />

Interleukin-13.<br />

Ribbon diagram of IL-13 that constitutes a theoretical model of human<br />

IL-13. This is the first of two alternative structures of IL-13 generated by<br />

homology modeling.<br />

interleukin-13 (IL13)<br />

A cytokine synthesized by numerous cell types, especially<br />

T helper type 2 (Th2) cells. A significant mediator<br />

of allergic inflammation and disease. It exerts effects on<br />

immune cells that resemble those of the closely related<br />

IL4 cytokine. It is a central mediator of allergic inflammation<br />

in numerous tissues. It induces its effects through<br />

a multisubunit receptor that includes the α chain of the<br />

IL4 receptor (IL4Rα) that is also a constituent of the<br />

IL4 receptor and one of two known IL13-specific binding<br />

chains. IL13’s biological effects are associated with a<br />

single transcription factor, signal transducer and activator<br />

of transcription 6 (STAT6). The functions of IL13 resemble<br />

those of IL4, especially with respect to changes induced<br />

on hematopoietic cells. IL13 can induce IgE secretion<br />

from activated human B cells. It acts as a molecular bridge<br />

linking allergic inflammatory cells to nonimmune cells in<br />

contact with them, thereby altering physiologic function. In<br />

addition to its role in the induction of airway disease, IL13<br />

also has anti-inflammatory properties. The protein degrading<br />

enzymes known as airway matrix metalloproteinases<br />

(MMPs) are requisite to induce egression of effete parenchymal<br />

inflammatory cells into the airway lumen where<br />

they are cleared. IL13 induces these MMPs as a mechanism<br />

to protect against excessive allergic inflammation that<br />

may lead to asphyxiation. IL13 facilitates the expulsion<br />

of offending organisms or their products from parasitized<br />

organs. Expulsion of helminths from the mouse gut<br />

required IL13 secreted by Th2 cells. The cytokine fosters<br />

an environment hostile to the parasite, including enhanced<br />

contractions and glycoprotein hypersecretion from gut<br />

epithelial cells, leading ultimately to detachment of the<br />

organism from the gut wall and its removal. Schistosoma<br />

mansoni eggs may lodge in various organs and tissues<br />

including the gut wall, liver, lung, and central nervous system,<br />

leading to the formation of granulomas with the control<br />

of IL13. This leads ultimately to organ injury and often<br />

significant or fatal disease, not resolution of the infection.<br />

IL13 may antagonize Th1 responses required for resolution<br />

of intracellular infections, leading to recruitment of aberrantly<br />

large numbers of Th2 cells. IL13 inhibits the ability<br />

of host immune cells to destroy intracellular pathogens. It<br />

mediates many features of allergic lung disease including<br />

airway hyperresponsiveness, goblet cell metaplasia, and<br />

mucus hypersecretion, all of which contribute to airway<br />

obstruction. IL4 also contributes to these changes but is less<br />

significant than IL13 in that regard. IL13 induces secretion<br />

of chemokines needed for recruitment of allergic effector<br />

cells to the lung. STAT6 transgenic mouse investigations<br />

reveal the possibility that IL13 signaling occurring only<br />

through the airway epithelium is requisite for most of these<br />

effects. The high affinity IL13 receptor complex consists of<br />

the IL4Rα chain and an IL13-binding protein designated<br />

the IL13Rα chain. The IL13 receptor is expressed on B<br />

cells, monocytes/macrophages, basophils, mast cells, and<br />

endothelial cells but not on T cells. The IL13R complex<br />

also acts as a second receptor for IL4. The IL13Rα chain is<br />

a specific binding protein for IL13. IL4 can signal through<br />

both IL13R and IL4R complexes. Both IL4 and IL13 can<br />

mediate their biological actions through the IL13R complex.<br />

interleukin-14 (IL14)<br />

Formerly known as high molecular-weight B cell growth<br />

factor (HMW-BCGF), IL14 is a cytokine produced by follicular<br />

dendritic cells, germinal center T cells, and some<br />

malignant B cells. Normal and malignant B cells, notably<br />

germinal center B cells and NHL-B cells, respectively,<br />

express receptors for IL14. Its predominant activity is to<br />

enhance the proliferation of B cells and induce memory B<br />

cell production and maintenance. It also inhibits antibody<br />

secretion. It is synthesized principally by T cells and<br />

selected malignant B cells. Work with NHL-B cell lines<br />

has shown that inhibition of the expression of the IL14 gene<br />

results in diminished cell growth and eventual cell death.<br />

Also called taxilin. Two distinct transcripts produced from<br />

opposite strands of the il14 locus gene are called IL14α and

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!